These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6784733)

  • 1. alpha-Difluoromethylornithine (alpha DFMO) and phenoxybenzamine hydrochloride in the treatment of chronic non-suppurative prostatitis.
    Dunzendorfer U
    Arzneimittelforschung; 1981; 31(2):382-5. PubMed ID: 6784733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alpha-difluromethylornithine and tartaric acid on sperm count, seminal gamma GT, FSH, LH, testosterone and steroid excretion in patients with chronic prostatitis.
    Dunzendorfer U; Feller H
    Andrologia; 1981; 13(2):100-7. PubMed ID: 6113790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alpha-blockers and bioflavonoids in men with chronic nonbacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial].
    Lü M; Zhao ST; Wang SM; Shi BK; Fan YD; Wang JZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):169-72. PubMed ID: 15132876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
    Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-blind placebo-controlled trial of terazosine efficacy in patients with chronic abacterial prostatitis].
    Sivkov AV; Oshchepkov VN; Egorov AA
    Urologiia; 2005; (1):47-53. PubMed ID: 15776832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial.
    Pendyala L; Creaven PJ; Porter CW
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):235-41. PubMed ID: 8318876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics.
    Barbalias GA; Nikiforidis G; Liatsikos EN
    J Urol; 1998 Mar; 159(3):883-7. PubMed ID: 9474175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study.
    Elist J
    Urology; 2006 Jan; 67(1):60-3. PubMed ID: 16413333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
    O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
    Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis].
    Wang J; Li J; Lu R; Wang JM
    Zhonghua Nan Ke Xue; 2002; 8(1):48-50. PubMed ID: 12479049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
    Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
    Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study of prostat combined with an antibiotic for chronic nonbacterial prostatitis].
    Ye ZQ; Lan RZ; Wang SG; Cai SL; Chen GM; Li NC; Song Y; Na YQ
    Zhonghua Nan Ke Xue; 2006 Sep; 12(9):807-10. PubMed ID: 17009533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
    Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
    Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
    Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
    Bates SM; Hill VA; Anderson JB; Chapple CR; Spence R; Ryan C; Talbot MD
    BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC; Pontari M; Moon T; Gittelman M; Malek G; Farrington J; Pearson J; Krupa D; Bach M; Drisko J;
    J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination regimen in the treatment of chronic prostatitis.
    Chen WM; Yang CR; Ou YC; Ho HC; Su CK; Chiu KY; Cheng CL
    Arch Androl; 2006; 52(2):117-21. PubMed ID: 16443588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.